Parthenolide inhibits the proliferation and migration of cervical cancer cells via FAK/GSK3β pathway

PurposeCervical cancer (CC) ranks as the fourth most prevalent malignancy among women worldwide, necessitating effective therapeutic interventions to mitigate its detrimental impact on both physical and mental health. Parthenolide (PTL), a natural product of the sesquiterpene lactone derived from Feverfew leaves, has exhibited promising anti-tumor properties in previous studies; however, its precise effects and underlying molecular mechanisms in CC remain elusive.MethodsIn this work, we investigated the effect of PTL on the proliferation and migration of CC cells. Western blot analysis and Reverse transcription-quantitative PCR were used for mechanistic elucidation.ResultsOur findings indicated that PTL substantially inhibited the proliferation of HeLa and SiHa CC cell lines in a dose- and time-dependent manner. Moreover, PTL significantly suppressed the migration of CC cells by down-regulating the expression of vascular endothelial growth factor (VEGF), metastasis-associated protein 1 (MTA1), and transforming growth factor-beta 1 (TGF-beta 1). Mechanistically, PTL blocked the phosphorylation of focal adhesion kinase (FAK) and glycogen synthase kinase-3 beta (GSK3 beta) induced by epidermal growth factor (EGF). Further investigations revealed that PTL suppressed the proliferation of CC cells by inhibiting the EGF-mediated phosphorylation of the FAK/GSK3 beta signaling pathway.ConclusionTaken together, the present in vitro results suggest that PTL may inhibit the proliferation and migration of CC cells through down-regulating the FAK/GSK3 beta signaling pathway, providing new insights for the application of PTL in the treatment of CC.